dbo:abstract | - Bromethenmadinone acetate (BMMA, also known as bromsuperlutin) is a progestin medication which was developed in Czechoslovakia and was described in 1970 but was never marketed. Analogues of BMMA include chlormethenmadinone acetate, melengestrol acetate, and methenmadinone acetate. (en)
|
dbo:casNumber | |
dbo:chEMBL | |
dbo:class | |
dbo:pubchem | |
dbo:thumbnail | |
dbo:wikiPageID | |
dbo:wikiPageLength | - 6119 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID | |
dbo:wikiPageWikiLink | |
dbp:br | |
dbp:c | |
dbp:casNumber | |
dbp:chembl | |
dbp:chemspiderid | |
dbp:class | |
dbp:h | |
dbp:iupacName | - [-17-Acetyl-6-bromo-10,13-dimethyl-16-methylidene-3-oxo-1,2,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-yl] acetate (en)
|
dbp:o | |
dbp:pubchem | |
dbp:smiles | |
dbp:stdinchi | |
dbp:stdinchikey | - GIUDLKYATCHBDT-USYNNDFZSA-N (en)
|
dbp:synonyms | - BMMA; Bromsuperlutin; 6-Bromo-16-methylene-17α-hydroxy-Δ6-progesterone acetate; 6-Bromo-16-methylene-17α-acetoxypregna-4,6-diene-3,20-dione (en)
|
dbp:width | |
dbp:wikiPageUsesTemplate | |
dcterms:subject | |
rdf:type | |
rdfs:comment | - Bromethenmadinone acetate (BMMA, also known as bromsuperlutin) is a progestin medication which was developed in Czechoslovakia and was described in 1970 but was never marketed. Analogues of BMMA include chlormethenmadinone acetate, melengestrol acetate, and methenmadinone acetate. (en)
|
rdfs:label | - Bromethenmadinone acetate (en)
|
owl:sameAs | |
prov:wasDerivedFrom | |
foaf:depiction | |
foaf:isPrimaryTopicOf | |
isdbo:wikiPageRedirects of | |
isdbo:wikiPageWikiLink of | |
isfoaf:primaryTopic of | |